Nuvation Bio Inc. (NYSE:NUVB) went up by 12.57% from its latest closing price compared to the recent 1-year high of $10.45. The company’s stock price has collected 21.33% of gains in the last five trading sessions.
Is It Worth Investing in Nuvation Bio Inc. (NYSE :NUVB) Right Now?
Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Nuvation Bio Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $14.00, which is $10.46 above the current price. NUVB currently public float of 124.58M and currently shorts hold a 13.70% ratio of that float. Today, the average trading volume of NUVB was 836.99K shares.
NUVB’s Market Performance
NUVB stocks went up by 21.33% for the week, with a monthly jump of 11.38% and a quarterly performance of -20.72%, while its annual performance rate touched -56.10%. The volatility ratio for the week stands at 7.56% while the volatility levels for the past 30 days are set at 6.16% for Nuvation Bio Inc. The simple moving average for the period of the last 20 days is 18.09% for NUVB stocks with a simple moving average of -37.92% for the last 200 days.
Analysts’ Opinion of NUVB
Many brokerage firms have already submitted their reports for NUVB stocks, with H.C. Wainwright repeating the rating for NUVB by listing it as a “Buy.” The predicted price for NUVB in the upcoming period, according to H.C. Wainwright is $14 based on the research report published on May 04th of the current year 2022.
BTIG Research, on the other hand, stated in their research note that they expect to see NUVB reach a price target of $16. The rating they have provided for NUVB stocks is “Buy” according to the report published on October 15th, 2021.
RBC Capital Mkts gave a rating of “Outperform” to NUVB, setting the target price at $15 in the report published on April 06th of the previous year.
NUVB Trading at -1.80% from the 50-Day Moving Average
After a stumble in the market that brought NUVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.71% of loss for the given period.
Volatility was left at 6.16%, however, over the last 30 days, the volatility rate increased by 7.56%, as shares surge +16.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.46% lower at present.
During the last 5 trading sessions, NUVB rose by +21.33%, which changed the moving average for the period of 200-days by -55.96% in comparison to the 20-day moving average, which settled at $3.60. In addition, Nuvation Bio Inc. saw -50.47% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at NUVB starting from Omega Fund V, L.P., who sale 2,500,000 shares at the price of $5.60 back on Apr 05. After this action, Omega Fund V, L.P. now owns 20,457,340 shares of Nuvation Bio Inc., valued at $14,000,000 using the latest closing price.
Omega Fund V, L.P., the 10% Owner of Nuvation Bio Inc., sale 500,000 shares at $10.07 during a trade that took place back on Dec 15, which means that Omega Fund V, L.P. is holding 22,957,340 shares at $5,035,000 based on the most recent closing price.
Stock Fundamentals for NUVB
Equity return is now at value -11.60, with -11.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 45.62.